Perceiv AI
Predicting disease progression with AI
- Headquarters
- San Francisco Bay Area
- Business Model
- B2B
- Website
- perceiv.ai
- Last Round
- SeedDec 2022
About
Perceiv AI is a Toronto-based artificial intelligence company that uses multimodal data and machine learning to predict disease progression for clinical trials and pharmaceutical drug development. The platform analyzes imaging, biomarker, and clinical data to generate predictive models that help drug developers identify the right patients, design more efficient trials, and reduce attrition. Perceiv AI's technology is particularly focused on neurodegenerative diseases such as Alzheimer's.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account